Paradigm Health
News,AI,HealthTech,Asia,Biotech / MedTech
Fujitsu and Paradigm test AI screening for Japan trials
Fujitsu, a Japanese cancer center and Paradigm used AI to narrow clinical-trial candidates and reduce records requiring manual review by 89 percent.
November 20, 2026



